Dr. Munoz is Associate Professor of Pediatrics, Infectious Diseases, Molecular Virology and Microbiology at Baylor College of Medicine, and Director of Transplant Infectious Diseases at Texas Children’s Hospital, in Houston, TX. She is a physician-scientist with projects focusing on the epidemiology of respiratory infections in healthy and immunocompromised hosts, and the evaluation of vaccines in pregnant women and children. She has served as lead principal investigator (PI), co-investigator or site PI on numerous studies researching vaccines and treatments for SARS-CoV-2, zika virus, seasonal and pandemic influenza, pertussis and respiratory syncytial virus (RSV) in children and pregnant and non-pregnant adults. She currently leads the MOMI-Vax Study, an observational, prospective cohort study of the immunogenicity and safety of SARS-CoV-2 vaccines administered during pregnancy or postpartum and evaluation of antibody transfer and durability in infants.
Dr Muñoz was a member of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases (COID) until 2021, and is currently a member of the AAP Section of Infectious Diseases (SOID), the Influenza Work Group of the CDC’s Advisory Committee on Immunization Practices (ACIP), and the American College of Obstetricians and Gynecologists (ACOG) Immunization Expert Work Group. She also serves as chair of the Institutional Review Board at Baylor College of Medicine and is a member of several professional societies, including the Pediatric Infectious Diseases Society (PIDS) and the European Society of Pediatric Infectious Diseases (ESPID), and is Editor of the Maternal Neonatal Section of the Pediatric Infectious Diseases Journal. She is currently co-Chair of the Maternal Immunization working group of CEPI-SPEAC.